5 Key Takeaways

• 1

  Ophthalmologists should prioritize selective laser trabeculoplasty (SLT) and minimally invasive glaucoma surgery (MIGS) for early-stage glaucoma patients.

• 2

  Interventional glaucoma is an emerging field focused on optimizing treatment for patients with early-stage disease.

• 3

  Integrating SLT and MIGS early in the disease process can effectively slow progression and reduce field loss.

• 4

  Modifiable factors in the trabecular meshwork can be addressed more effectively when treatment begins early.

• 5

  The goal of interventional glaucoma is to enhance long-term patient outcomes by managing disease progression.